先看重點
在89名中重度睡眠呼吸暫停且超重或肥胖的西班牙男性中,8週減重和生活方式介入使呼吸暫停低通氣指數下降21.2次/小時,與僅接受CPAP常規治療者相比組間差異為-23.6次/小時(95%置信區間-28.7~-18.5)。該試驗為開放標籤、樣本小且僅限男性,結果未必適用於女性或其他族群。
證據類型
隨機對照試驗
解讀依據
公開摘要
閱讀重點
對照與不確定性
研究在問什麼
肥胖是阻塞性睡眠呼吸暫停(OSA)的首要原因,但減重和生活方式介入對OSA及相關問題的作用仍不確定。作者在已使用持續氣道正壓通氣(CPAP)的男性中檢驗了一項跨學科介入。
研究對象與方法
2019年4月至2020年10月在西班牙格拉納達一家醫院轉診中心開展的平行組、開放標籤隨機臨床試驗(INTERAPNEA)。89名18至65歲、患中重度OSA、體重指數不低於25且正在接受CPAP治療的男性,被隨機分為常規治療(CPAP;49人)組,或在常規治療基礎上接受為期8週的介入(40人),內容包括營養行為改變、有氧運動、睡眠衛生以及戒酒戒菸。主要結局為介入結束時及介入後6個月呼吸暫停低通氣指數(AHI)的變化,次要結局包括體重和體成分、心血管代謝風險及生活質量。註冊號NCT03851653。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 18週時,介入組AHI下降21.2次/小時(降幅51%;95%置信區間-25.4~-16.9),對照組上升2.5次/小時(95%置信區間-2.0~6.9),組間差異為-23.6次/小時(95%置信區間-28.7~-18.5)。
- 2介入後6個月,介入組AHI降幅為57%,組間差異為-23.8次/小時(95%置信區間-28.3~-19.3)。
- 3不再需要CPAP:介入結束時為40人中的18人(45.0%),6個月時為34人中的21人(61.8%)。OSA完全緩解:先是40人中的6人(15.0%),後為34人中的10人(29.4%)。
- 4與對照組相比,介入組在體重(-7.1 kg對-0.3 kg)、脂肪量(-2.9 kg對1.4 kg)、血壓(-6.5 mm Hg對2.2 mm Hg)和睡眠呼吸暫停生活質量指數(0.8分對0.1分)方面改善也更大。
限制與不確定性
- 1僅89名男性、來自西班牙一家醫院,結果未必適用於女性、其他族裔或較輕的OSA。
- 2試驗為開放標籤,參與者和工作人員都知道誰接受了介入。
- 36個月時介入組的追蹤人數(34人,基線為40人)有所減少,摘要未說明失訪原因。
- 4介入由多個部分組成,摘要無法說明是哪一部分帶來了獲益。本解讀僅基於摘要。
日常健康啟示
對超重的男性睡眠呼吸暫停患者,結合減重、運動、睡眠習慣及減少菸酒的系統方案可能改善呼吸暫停的嚴重程度,但這只是一項規模較小的試驗。這並不意味著可以自行停用CPAP,治療調整應由睡眠專科醫師指導。
如何連結自己的資料
如果你的穿戴式裝置能估算呼吸紊亂或血氧,可以看到夜間變化趨勢,但它不能代替測量AHI的睡眠監測。體重和晨起血壓建議每週用同一臺體重秤和血壓計記錄,並把趨勢告訴醫師。
如何理解這類證據
隨機分組有助於因果推斷,仍須檢查分配、盲法、失去追蹤、追蹤時間和具體對照;標為隨機試驗不自動意味著高確定性。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Importance
Obesity is the leading cause of obstructive sleep apnea (OSA); however, the effects of weight loss and lifestyle interventions on OSA and comorbidities remain uncertain.
Objective
To evaluate the effect of an interdisciplinary weight loss and lifestyle intervention on OSA and comorbidities among adults with moderate to severe OSA and overweight or obesity.
Design, setting, and participants
The Interdisciplinary Weight Loss and Lifestyle Intervention for OSA (INTERAPNEA) study was a parallel-group open-label randomized clinical trial conducted at a hospital-based referral center in Granada, Spain, from April 1, 2019, to October 23, 2020. The study enrolled 89 Spanish men aged 18 to 65 years with moderate to severe OSA and a body mass index (calculated as weight in kilograms divided by height in meters squared) of 25 or greater who were receiving continuous positive airway pressure (CPAP) therapy. The sole inclusion of men was based on the higher incidence and prevalence of OSA in this population, the differences in OSA phenotypes between men and women, and the known effectiveness of weight loss interventions among men vs women.
Interventions
Participants were randomized to receive usual care (CPAP therapy) or an 8-week weight loss and lifestyle intervention involving nutritional behavior change, aerobic exercise, sleep hygiene, and alcohol and tobacco cessation combined with usual care.
Main outcomes and measures
The primary end point was the change in the apnea-hypopnea index (AHI) from baseline to the intervention end point (8 weeks) and 6 months after intervention. Secondary end points comprised changes in other OSA sleep-related outcomes, body weight and composition, cardiometabolic risk, and health-related quality of life.
Results
Among 89 men (mean [SD] age, 54.1 [8.0] years; all of Spanish ethnicity; mean [SD] AHI, 41.3 [22.2] events/h), 49 were randomized to the control group and 40 were randomized to the intervention group. The intervention group had a greater decrease in AHI (51% reduction; change, -21.2 events/h; 95% CI, -25.4 to -16.9 events/h) than the control group (change, 2.5 events/h; 95% CI, -2.0 to 6.9 events/h) at the intervention end point, with a mean between-group difference of -23.6 events/h (95% CI, -28.7 to -18.5 events/h). At 6 months after intervention, the reduction in AHI was 57% in the intervention group, with a mean between-group difference of -23.8 events/h (95% CI, -28.3 to -19.3 events/h). In the intervention group, 18 of 40 participants (45.0%) no longer required CPAP therapy at the intervention end point, and 6 of 40 participants (15.0%) attained complete OSA remission. At 6 months after intervention, 21 of 34 participants (61.8%) no longer required CPAP therapy, and complete remission of OSA was attained by 10 of 34 participants (29.4%). In the intervention vs control group, greater improvements in body weight (change, -7.1 kg [95% CI, -8.6 to -5.5 kg] vs -0.3 kg [95% CI, -1.9 to 1.4 kg]) and composition (eg, change in fat mass, -2.9 kg [95% CI, -4.5 to -1.3 kg] vs 1.4 kg [95% CI, -0.3 to 3.1 kg]), cardiometabolic risk (eg, change in blood pressure, -6.5 mm Hg [95% CI, -10.3 to -2.6 mm Hg] vs 2.2 mm Hg [95% CI, -2.1 to 6.6 mm Hg]), and health-related quality of life (eg, change in Sleep Apnea Quality of Life Index, 0.8 points [95% CI, 0.5-1.1 points] vs 0.1 points [95% CI, -0.3 to 0.4 points]) were also found at the intervention end point.
Conclusions and relevance
In this study, an interdisciplinary weight loss and lifestyle intervention involving Spanish men with moderate to severe OSA and had overweight or obesity and were receiving CPAP therapy resulted in clinically meaningful and sustainable improvements in OSA severity and comorbidities as well as health-related quality of life. This approach may therefore be considered as a central strategy to address the substantial impact of this increasingly common sleep-disordered breathing condition.
Trial registration
ClinicalTrials.gov Identifier: NCT03851653.
來源與署名
Effect of an Interdisciplinary Weight Loss and Lifestyle Intervention on Obstructive Sleep Apnea Severity: The INTERAPNEA Randomized Clinical Trial.
Carneiro-Barrera A, Amaro-Gahete FJ, Guillén-Riquelme A, Jurado-Fasoli L, Sáez-Roca G, Martín-Carrasco C, Buela-Casal G, Ruiz JR.
JAMA network open · 2022-04-01
DOI: 10.1001/jamanetworkopen.2022.8212 ↗PubMed · 35452108 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
運動改善45歲及以上睡眠障礙者的睡眠質量評分
彙總23項隨機對照試驗、共1,478名45至77歲睡眠障礙成年人的資料,運動改善了匹茲堡睡眠質量指數評分(SMD 0.62,95%置信區間0.40–0.83),網路分析中有氧運動效果最大(SMD 1.34,95%可信區間0.86–1.82)。證據確定性為低到中等,結局是問卷評分,每週約539 MET-min的最佳劑量是模型估計值,不是處方。
Journal of Exercise Science & Fitness
睡眠規律性比睡眠時長更能預測英國成年人的死亡風險
在60,977名佩戴腕式加速度計一週的英國生物樣本庫成年人中,睡眠最規律的五分之一族群,經完全校正後的全因死亡風險比為0.70(95%置信區間0.59–0.83),對照為最不規律的五分之一,追蹤約6.3年,共1859人死亡。規律性對資料的擬合優於睡眠時長,但這是隻依據一週資料的觀察性研究。
Sleep
延長睡眠使超重成年人每日能量攝取減少約270千卡
在80名平時睡眠不足6.5小時的超重成年人中,兩週的延長睡眠指導使睡眠增加約1.2小時,實測能量攝取比對照組少270.4千卡/天(95%置信區間−393.4至−147.4)。這是一項為期短、單中心、族群較窄的試驗,不能說明體重會持續下降,也不能說明對睡眠本就充足的人有益。
JAMA Internal Medicine
50歲和60歲時每晚睡6小時及以下,與日後失智風險較高相關
在7959名英國公務員中追蹤約25年,50歲時每晚睡6小時及以下者的失智風險比為1.22(95%置信區間1.01–1.48),60歲時為1.37(1.10–1.72),均高於睡7小時者;長期持續睡眠偏短者為1.30(1.00–1.69)。睡眠主要靠自報,且為觀察性研究,早期腦部病變等因素可能解釋了部分關聯。
Nature Communications

